Skip to main content
. 2013 Jul 14;24(10):2601–2606. doi: 10.1093/annonc/mdt249

Figure 1.

Figure 1.

Mean (±SD) Plasma concentrations of sepantronium bromide (YM155) in NSCLC patients after 72-h continuous infusion.